424 related articles for article (PubMed ID: 26186560)
21. Respiratory syncytial virus risk factors in late preterm infants.
Lanari M; Silvestri M; Rossi GA
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():102-7. PubMed ID: 19925369
[TBL] [Abstract][Full Text] [Related]
22. Respiratory Syncytial Virus Associated Hospitalizations in Infants of 33 to 42 Weeks' Gestation: Does Gestational Age Matter?
Resch B; Wörner C; Özdemir S; Hubner M; Puchas C; Urlesberger B
Klin Padiatr; 2019 Jul; 231(4):206-211. PubMed ID: 30887492
[TBL] [Abstract][Full Text] [Related]
23. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
Lacaze-Masmonteil T; Rozé JC; Fauroux B;
Pediatr Pulmonol; 2002 Sep; 34(3):181-8. PubMed ID: 12203846
[TBL] [Abstract][Full Text] [Related]
24. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
Heikkinen T; Valkonen H; Lehtonen L; Vainionpää R; Ruuskanen O
Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
[TBL] [Abstract][Full Text] [Related]
25. Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.
Winterstein AG; Knox CA; Kubilis P; Hampp C
JAMA Pediatr; 2013 Dec; 167(12):1118-24. PubMed ID: 24126903
[TBL] [Abstract][Full Text] [Related]
26. Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.
Maksić H; Heljić S; Skokić F; Šumanović-Glamuzina D; Milošević V; Zlatanović A; Gerard N
Bosn J Basic Med Sci; 2018 Aug; 18(3):279-288. PubMed ID: 29750895
[TBL] [Abstract][Full Text] [Related]
27. RSV hospitalization in infancy increases the risk of current wheeze at age 6 in late preterm born children without atopic predisposition.
Korsten K; Blanken MO; Buiteman BJM; Nibbelke EE; Naaktgeboren CA; Bont LJ; Wildenbeest JG
Eur J Pediatr; 2019 Apr; 178(4):455-462. PubMed ID: 30637465
[TBL] [Abstract][Full Text] [Related]
28. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.
Hall CB; Weinberg GA; Blumkin AK; Edwards KM; Staat MA; Schultz AF; Poehling KA; Szilagyi PG; Griffin MR; Williams JV; Zhu Y; Grijalva CG; Prill MM; Iwane MK
Pediatrics; 2013 Aug; 132(2):e341-8. PubMed ID: 23878043
[TBL] [Abstract][Full Text] [Related]
29. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
Henckel E; Luthander J; Berggren E; Kapadia H; Naver L; Norman M; Bennet R; Eriksson M
Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
[TBL] [Abstract][Full Text] [Related]
30. Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.
Jalink MB; Langley JM; Dodds L; Andreou P
Pediatr Infect Dis J; 2019 Nov; 38(11):1121-1125. PubMed ID: 31425330
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of respiratory syncytial virus infection in infants born at less than thirty-five weeks of gestational age.
Park HW; Lee BS; Kim AR; Yoon HS; Kim BI; Song ES; Kim WT; Lim J; Kim S; Jin HS; Byun S; Chee DH; Kim KS
Pediatr Infect Dis J; 2012 Aug; 31(8):e99-104. PubMed ID: 22531234
[TBL] [Abstract][Full Text] [Related]
32. Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations.
Bennett MV; McLaurin K; Ambrose C; Lee HC
PLoS One; 2018; 13(10):e0205399. PubMed ID: 30379957
[TBL] [Abstract][Full Text] [Related]
33. Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study.
Papenburg J; Defoy I; Massé E; Caouette G; Lebel MH
J Pediatric Infect Dis Soc; 2021 Apr; 10(3):237-244. PubMed ID: 32530035
[TBL] [Abstract][Full Text] [Related]
34. Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data.
Kong AM; Winer IH; Zimmerman NM; Diakun D; Bloomfield A; Gonzales T; Fergie J; Goldstein M; Krilov LR
Am J Perinatol; 2023 Oct; 40(14):1529-1536. PubMed ID: 34704241
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.
Liese JG; Grill E; Fischer B; Roeckl-Wiedmann I; Carr D; Belohradsky BH;
Eur J Pediatr; 2003 Apr; 162(4):230-6. PubMed ID: 12647195
[TBL] [Abstract][Full Text] [Related]
36. Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey.
Oncel MY; Mutlu B; Kavurt S; Baş AY; Demirel N; Akyol M; Erdeve O; Dilmen U
Turk J Pediatr; 2012; 54(4):344-51. PubMed ID: 23692714
[TBL] [Abstract][Full Text] [Related]
37. National Evidence in Israel Supporting Reevaluation of Respiratory Syncytial Virus Prophylactic Guidelines.
Gross I; Siedner-Weintraub Y; Abu Ahmad W; Bar-Oz B; Eventov-Friedman S
Neonatology; 2017; 111(3):240-246. PubMed ID: 27898422
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Respiratory Syncytial Virus Infections in Moderate/Late Premature Infants in Turkey: A Prospective Multicenter Epidemiological Study.
Ozkan H; Celebi S; Koksal N; Hacımustafaoğlu M; Koc E; Tezer H; Cetinkaya M; Cebeci B; Erdeve O; Ozdemir H;
Am J Perinatol; 2021 Dec; 38(14):1540-1546. PubMed ID: 32659789
[TBL] [Abstract][Full Text] [Related]
40. The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.
Kong AM; Krilov LR; Fergie J; Goldstein M; Diakun D; Wade SW; Pavilack M; McLaurin KK
Am J Perinatol; 2018 Jan; 35(2):192-200. PubMed ID: 28881376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
